Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04675476

A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening

To test the impact of a multilevel intervention on primary (provider-patient communication, intentions, and knowledge) and secondary (screening referrals and completion) outcomes.

Recruiting

Interested in participating?

Request Info

Key information

Age range

50 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

MedStar Health

Washington D.C., District of Columbia, 20007, United States

Location status: Recruiting

Location contact

Andrew Canning

CONTACT

About this study

The proposed study will target two key levels of influence in the healthcare setting: provider and patient behavior in order to address disparities between African American and whites in lung screening awareness and utilization. Guided by NIH's Health Disparities Research Framework and building on the formative work conducted in the K99 phase, we will conduct a quasi-experimental study (pretest-posttest, with a nonequivalent control group) in partnership with four primary care clinics within the MedStar Health system in the R00 phase.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 50-80 years old;
  • current cigarette smoker or quit within 15 years;
  • a 20+ pack-year smoking history;
  • non-adherent to lung screening (>13 months);
  • English-speaking;
  • scheduled for an upcoming clinic appointment (4 weeks - 8 weeks); and
  • able and willing to provide meaningful consent and complete telephone interviews

Exclusion criteria

  • Individuals with a history of lung cancer

Treatment and study plan

Provider Prompt & Patient Outreach and Education

Behavioral

To target lack of provider-prompted discussion about lung screening, an electronic medical record (EMR) message will be sent to primary care providers prior to scheduled visits with screening-eligible patients to notify them of the patient's eligibility and to encourage discussion of the benefits and limitations of the test. To target patient-level knowledge about lung screening, an outreach specialist will educate screening-eligible patients about the benefits and limitations of the test prior to their visit.

Primary outcomes

  1. provider-patient discussion

    Time frame: 1-week post-visit

    Discussion about lung screening with the provider ('did you have a discussion with your doctor about lung screening?')

  2. lung cancer screening intentions

    Time frame: 1-week post-visit

    Screening intentions ('how likely is it that you will undergo lung screening in the next 6-months?')

  3. lung cancer screening knowledge

    Time frame: 1-week post-visit

    Lung cancer screening knowledge measure

Secondary outcomes

  1. lung cancer screening referrals

    Time frame: 6-months

    Total number of lung screening orders captured via the electronic medical record

  2. lung cancer screening completion rates

    Time frame: 6-months

    Total number of lung screening completions captured via the electronic medical record

Study contacts

Contact information is provided by the study sponsor or research team.

Randi M Williams, PhD

CONTACT

[email protected]

(202) 687-7036

Sponsors and collaborators

Lead sponsor

Georgetown University

Other

Registry information

Official study title

A Multilevel Intervention to Address Health Disparities in Lung Cancer Screening

Important dates

Study start
2024
Primary completion
2025
Study completion
2026
First posted
Dec 19, 2020
Registry last updated
Dec 27, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.